Navigation Links
'Exoskeleton' Helps Paralyzed Stand, Take Steps
Date:1/13/2012

By Amanda Gardner
HealthDay Reporter

THURSDAY, Jan. 12 (HealthDay News) -- Veteran ski patrol member Mike Rhode was speeding down a snowy slope at Hunter Mountain in New York state when his ski unexpectedly popped off.

Rhode, then a member of the ski patrol for 13 years, wasn't able to regain his balance before hitting a fence. Now, tragically, he is paralyzed from the chest down.

But last October, 10 months after the accident, Rhode was able to walk again with the assistance of Ekso, a robotic "exoskeleton" that he and five other testers "wore" on their body during an initial trial, enabling them to stand up and even take steps.

"I was upright for an hour and 10 minutes and was actually walking for 31 minutes," said Rhode, 46. "It was such a positive feeling."

Ekso is one of just a few robotic "exoskeletons" giving paraplegics and quadraplegics something they may never have dreamed of before: the ability to stand and walk on their own again.

With the Ekso that Rhode tested, "the therapist controls the sit-to-stand and moving forward," explains Dr. Steven Kirshblum, medical director and director of Spinal Cord Injury Services at the Kessler Institute for Rehabilitation in West Orange, N.J.

All Rhode had to do was start pushing out of his wheelchair as he had done many times before and the Ekso, as manipulated by the therapist, did the rest.

Kessler, a leader in the field of disability rehabilitation, is one of 10 U.S. organizations partnering with Ekso Bionics to develop clinical versions of the device.

A clinical model is due out "very soon," said Kirshblum. That model will allow the individual patient to control the device, can be for home use and will have the ability to negotiate stairs, he said.

"This will occur via wireless communication between the crutches and the sensors on the exoskeleton, assuring the individual is in the appropriate position and is safe to undertak
'/>"/>

Copyright©2010 ScoutNews,LLC.
All rights reserved

3

GOOD

Page: 1 2 3

Related medicine news :

1. New educational program helps the siblings of children with cancer
2. Whiff of love hormone helps monkeys show a little kindness
3. Downloadable tool helps cancer survivors plan and monitor exercise
4. Mid-lane driving helps older adults stay safe
5. If you plan, then youll do… but it helps to have a friend
6. BINGO! game helps researchers study perception deficits
7. Quantitative CT helps identify COPD patients at risk for exacerbations
8. Vitamin D Helps Bone Health Only With Calcium: Report
9. Calorie Info Helps Teens Choose Water Over Sugary Drinks
10. Online guide helps health organizations adopt electronic health records
11. In third-degree burn treatment, hydrogel helps grow new, scar-free skin
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2012)... are critical for determining effectiveness of medical therapies, ... for these studies compared with other western countries, ... Canadian Medical Association Journal ). , Dr. Salim ... Ontario, with Dr. John Cairns, University of British ... Canada should provide better financial support of clinical ...
(Date:5/22/2012)... LEXINGTON, Ky. (May 17, 2012) The University of ... million to study a deadly blood and bone marrow ... $5 million grant from the Edward P. Evans Foundation, ... research of myelodysplastic syndrome (MDS). , The Evans Foundation ... including three labs at UK, one at Cincinnati Children,s ...
(Date:5/22/2012)... (Phoenix, AZ May 22, 2012) -- Researchers at ... Medical Center have unveiled how and why the ... that could have real-world implications in military tactics, ... Barrow,s Laboratory of Visual Neuroscience, and Stephen Macknik, ... well known for their research into magic and ...
(Date:5/22/2012)... Alan Mozes HealthDay Reporter , , TUESDAY, May ... some headway is being made in both the detection ... front, researchers from two Cleveland institutions said they have ... kick-start the patient,s immune system into attacking cancer cells. ... School of Medicine and the Seidman Cancer Center at ...
(Date:5/22/2012)... 2012) -- Up to half of all prostate cancer cells ... gene and formation of its unique protein -- but no ... Weill Cornell Medical College researchers have found that in these ... a little ball known as a chromatin, is warped in ... thousands of genes, turning them on or off to promote ...
Breaking Medicine News(10 mins):Health News:Canada should significantly increase its funding of randomized clinical trials 2Health News:Markey receives $6.25 million to study deadly blood and bone marrow disease 2Health News:Markey receives $6.25 million to study deadly blood and bone marrow disease 3Health News:Barrow researchers use magic for discoveries 2Health News:Studies See Advances in Detecting, Treating Pancreatic Cancer 2Health News:Studies See Advances in Detecting, Treating Pancreatic Cancer 3Health News:Studies See Advances in Detecting, Treating Pancreatic Cancer 4Health News:Scientists unravel role of fusion gene in prostate cancer 2Health News:Scientists unravel role of fusion gene in prostate cancer 3Health News:Scientists unravel role of fusion gene in prostate cancer 4
... COPD Population Will Rise by Nearly 19 Percent as a Result ... from Decision ... Resources, ... leading research and advisory firms for pharmaceutical and,healthcare issues, finds that ...
... shelter for virus out of reach of drugs , , ... a certain type of cell provides a "hideout" for HIV ... humans. , These follicular dendritic cells (FDCs) are located throughout ... researchers at Brigham Young University and Johns Hopkins School of ...
... healthcare system better understand where to focus ... it offers, CAMBRIDGE, MA, May 28 /PRNewswire/ ... and safety software that helps organizations manage,infection control ... medical incidents, claims and quality issues,announced today that ...
... Glycoproducts International,Inc., a provider of nutritional supplement ... sitting in the Northern District of Texas ... Glycoproducts International, Inc.,committed patent infringement of two ... Mannatech,s AMBROTOSE(R) technology., The jury ruled ...
... ANGELES, May 28 5-year-old Noor came to,the attention ... 1st,Battalion, 30th Infantry Regiment, 2nd Brigade Combat Team through ... resulted,in the death of the little girl,s uncle. The ... surgeon, concluded that Noor is blind,due to a birth ...
... standards and the life style connected to them seem ... symptoms. This has lead to the assumption that the ... structures or to exogenous non-infectious proteins, i.e. allergens, when ... protect the individual from infections. , The European ...
Other Medicine News:Health News:Emerging Combination Therapies, Including Drugs from Novartis/Schering-Plough and GlaxoSmithKline/Theravance Will Drive the COPD Drug Market to More Than $11 Billion in 2017 2Health News:Scientists Break Into HIV 'Hideout' 2Health News:Caritas Christi Standardizes on rL Solutions to Help Deliver Best in Class Healthcare Quality 2Health News:Jury Rules in Favor of Glycoproducts International, Inc. 2Health News:Photos: Los Angeles Non Profit Teams With US Troops Stationed in Baghdad and Buaytha in Bringing a 5-Year-Old Blind Iraqi Girl, Whose Father Stands Beside US Combat Team Against Al Qaeda, to the US for a Groundbreaking Artificial Corneal Transplant Surger 2Health News:Researchers from 5 countries to test hygiene hypothesis with EU funding 2
(Date:5/22/2012)... Serbia, May 22, 2012 Sorbent Therapeutics, ... and renal diseases, presented positive data from its ... study of 111 heart failure patients with chronic ... symptoms as compared to placebo.    ... were presented in an oral session at the ...
(Date:5/22/2012)... -- GeoVax Labs, Inc. (OTCQB/OTCBB: GOVX), an Atlanta-based ... Human Immunodeficiency Virus (HIV) infections, today announced that ... opened enrollment for a Phase 1 trial for ... is identical to the first generation ... for the inclusion of granulocyte-macrophage colony-stimulating factor (GM-CSF) ...
(Date:5/22/2012)...   USANA Health Sciences , Inc. (NYSE: ... announced the promotion of Dr. John Cuomo to executive ... Dixon to executive director of new product and technological ... Mark Levy, a Ph.D. in human nutrition, and John ... professor at the University of Utah, have joined USANA,s ...
Breaking Medicine Technology:Sorbent Therapeutics' CLP1001 Improves Heart Failure Symptoms In Phase 2 Clinical Study 2Sorbent Therapeutics' CLP1001 Improves Heart Failure Symptoms In Phase 2 Clinical Study 3HIV Vaccine Trials Network Opens Enrollment for Phase 1 Trial of GeoVax Labs' Second Generation HIV Vaccine 2HIV Vaccine Trials Network Opens Enrollment for Phase 1 Trial of GeoVax Labs' Second Generation HIV Vaccine 3HIV Vaccine Trials Network Opens Enrollment for Phase 1 Trial of GeoVax Labs' Second Generation HIV Vaccine 4USANA Health Sciences Expands Award-Winning Research and Development Team 2USANA Health Sciences Expands Award-Winning Research and Development Team 3Access Pharmaceuticals and CuraScript Team Up to Further Expand MuGard Market Access and Distribution 20047 1Access Pharmaceuticals and CuraScript Team Up to Further Expand MuGard Market Access and Distribution 20047 2Access Pharmaceuticals and CuraScript Team Up to Further Expand MuGard Market Access and Distribution 20047 3Access Pharmaceuticals and CuraScript Team Up to Further Expand MuGard Market Access and Distribution 20047 4PDL BioPharma Announces Conversion Rate Adjustments for Its Convertible Notes 20044 1PDL BioPharma Announces Conversion Rate Adjustments for Its Convertible Notes 20044 2Debiopharm and Ascenta Therapeutics Inc Announce An Exclusive License Agreement for the Development and Commercialization of the IAP 28Inhibitor of 20439 1Debiopharm and Ascenta Therapeutics Inc Announce An Exclusive License Agreement for the Development and Commercialization of the IAP 28Inhibitor of 20439 2Debiopharm and Ascenta Therapeutics Inc Announce An Exclusive License Agreement for the Development and Commercialization of the IAP 28Inhibitor of 20439 3
... week ARTEMIS data presented at ICAAC -, ... today from a phase 3, randomized, open-label, ongoing ... infected adults,taking PREZISTA(R) 800 mg (two 400 mg ... an undetectable viral load (<50 copies/mL) at week ...
... Phase III studies affirmed the clinical benefits of,ACTEMRA ... from two Phase III studies,showed that patients who ... arthritis (RA) achieved significant improvements in signs and,symptoms ... combination,with methotrexate compared with methotrexate alone. The final ...
Other Medicine Technology:Long-Term Study Evaluates Boosted PREZISTA(R) Vs. Lopinavir/Ritonavir as Part of HIV Combination Therapy in Treatment-Naive Adults 2Long-Term Study Evaluates Boosted PREZISTA(R) Vs. Lopinavir/Ritonavir as Part of HIV Combination Therapy in Treatment-Naive Adults 3Long-Term Study Evaluates Boosted PREZISTA(R) Vs. Lopinavir/Ritonavir as Part of HIV Combination Therapy in Treatment-Naive Adults 4Long-Term Study Evaluates Boosted PREZISTA(R) Vs. Lopinavir/Ritonavir as Part of HIV Combination Therapy in Treatment-Naive Adults 5Long-Term Study Evaluates Boosted PREZISTA(R) Vs. Lopinavir/Ritonavir as Part of HIV Combination Therapy in Treatment-Naive Adults 6Long-Term Study Evaluates Boosted PREZISTA(R) Vs. Lopinavir/Ritonavir as Part of HIV Combination Therapy in Treatment-Naive Adults 7Long-Term Study Evaluates Boosted PREZISTA(R) Vs. Lopinavir/Ritonavir as Part of HIV Combination Therapy in Treatment-Naive Adults 8ACTEMRA (R) (tocilizumab) Significantly Reduced Signs and Symptoms of Rheumatoid Arthritis in Patients Who Failed Prior Treatments 2ACTEMRA (R) (tocilizumab) Significantly Reduced Signs and Symptoms of Rheumatoid Arthritis in Patients Who Failed Prior Treatments 3ACTEMRA (R) (tocilizumab) Significantly Reduced Signs and Symptoms of Rheumatoid Arthritis in Patients Who Failed Prior Treatments 4ACTEMRA (R) (tocilizumab) Significantly Reduced Signs and Symptoms of Rheumatoid Arthritis in Patients Who Failed Prior Treatments 5ACTEMRA (R) (tocilizumab) Significantly Reduced Signs and Symptoms of Rheumatoid Arthritis in Patients Who Failed Prior Treatments 6
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: